Ignite Creation Date:
2024-06-16 @ 11:49 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06434597
Status:
RECRUITING
Last Update Posted:
2024-07-11
First Post:
2024-05-23
Brief Title:
A Clinical Study of SPH5030 Tablets in the Treatment of Her2-positiveMutated Biliary Tract OR Colorectal Cancer Patients
Sponsor:
Shanghai Pharmaceuticals Holding Co Ltd
Organization:
Shanghai Pharmaceuticals Holding Co Ltd
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Biliary Tract or Colorectal Cancer With Her2-positiveMutated |
Keywords: